The Traderszone Network

Valeant Pharmaceuticals CEO J. Michael Pearson was hospitalized with a “severe case of pneumonia” and is receiving treatment, a company spokeswoman said.

“Anyone who has studied microeconomics knows… that an income transfer, as opposed to a gift in-kind, gets you to a higher level of utility,” but as WSJ reports, putting theory under the tree is another matter. After years of studying the economics of gift-giving, economists have found that some gifts are valued more highly than others, and that some gift-givers seem to be better than others…

read more

The magical properties of dollar-cost averaging

Valeant Pharmaceuticals Chief Executive J. Michael Pearson was hospitalized with severe pneumonia on Friday, the New York Times reported, citing a company spokeswoman.

Valeant Pharmaceuticals International Inc (VRX.TO) Chief Executive J. Michael Pearson was hospitalized with a “severe case of pneumonia” on Friday and is receiving treatment, a company spokeswoman said. Pearson, 56, joined Valeant as CEO in September 2010 after a 23-year career at McKinsey & Company and became chairman of the board in 2010. Under Pearson’s leadership, the company has come under U.S. government scrutiny for acquiring off-patent drugs and drastically hiking the prices.

Shady practices cost digital advertisers billions each year and undermine faith in the market. Google recently took a step toward solving some of these problems.

A suspected Russian airstrike east of Damascus has killed Jaysh al Islam chief Zahran Alloush, Retuers reports.

read more